Dr. Delma L Broussard to Speak at SMi’s 4th Annual Prefilled Syringes West Coast Conference this June

PR8

SMi are delighted to welcome the latest speaker of the 4th annual Prefilled Syringes West Coast conference

LONDON, UNITED KINGDOM, May 16, 2019 /EINPresswire.com/ — SMi are delighted to welcome the latest speaker of the 4th annual Prefilled Syringes West Coast conference, Dr Delma L Broussard. In three weeks’ time the conference will commence in San Diego on June 3rd to 4th 2019.

Speaker Overview
Dr Delma Broussard, Director, Global Clinical Safety and Pharmacovigilance Physician, CEL Behring: ‘Overview of EU MDR Specific to Safety’.
• Overview of requirements for EU MDR
• Discuss new requirements for post-market surveillance
• Integration of post-market surveillance activities with risk management and clinical evaluation

Dr. Broussard received her Bachelor’s and Medical Degrees from Harvard University, and completed Paediatric residency and Gastroenterology training at the Children’s Hospital of Philadelphia.

Her industry career has spanned 20 years in Risk management of drugs/biologics and media devices either in PV directly, or as part of Regulatory Affairs or Medical Affairs/Clinical development positions. She currently has a strategic role at CSL Behring, under the Chief Safety Officer, focusing on Clinical safety of combination products and medical devices. Earlier in her career, she held senior roles at major pharmaceutical companies, including Merck and JNJ.
Delma is a board-certified paediatric gastroenterologist, formerly Associate Professor at University of Pennsylvania School of Medicine, with publications in peer-reviewed journals.

Download the brochure and full speaker line-up at: www.prefilled-syringes-westcoast.com/einpr8
The competitive Pre-Filled Syringes market has sparked great improvements as devices strive for higher quality, safety, and patient satisfaction. Pre-Filled Syringes West Coast is the perfect platform to strengthen knowledge in key principles such as human factors and patient centricity, connectivity and digital health, container closure integrity, the therapeutic opportunities of pre-filled, and manufacturing in the landscape of complex biologics, whilst honing in on emerging trends for parenteral devices.

Benefits for attending Prefilled Syringes West Coast include:
• Obtain insights into the new FDA draft guidance on human factors submissions, and the European Medical Device Regulation (EU MDR)
• Discover key innovations in digital health and how it can benefit pre-filled syringes
• Understand how silicon is being used to enhance formulation
• Explore the latest case studies in therapeutic opportunities
• Highlight the emerging trends of connected health and the future of drug delivery device designs

For those looking to attend, the conference takes place in three weeks’ time, so spaces are limited. Book your place at: www.prefilled-syringes-westcoast.com/einpr8

SMi presents the 4nd Annual Conference:
Pre-filled Syringes – West Coast 2019
Date: June 3-4, 2019
Workshops: June 5 21019
Location: Hyatt Regency Mission Bay, San Diego, California, USA

Sponsored by: Almac, Aptar, Credence MedSystems, Harro Hoefliger, Kaleidscope Innovation, Lonstroff Sumitomo Rubber North America, Mitsubishi Gas Chemical, Nemera, Plastic Ingenuity, PHC Corporation, Wilco, Zeon, ZebraSci, Zwick

—ENDS—

Contact Information:
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6048 / Email: hsidhu@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Jinna Sidhu
SMi Group
+1 2078276088
email us here


Source: EIN Presswire